PREDQ (Predictive Technology Group) YoY EPS Growth: 46.88% (As of Mar. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Predictive Technology Group YoY EPS Growth?

Predictive Technology Group PREDQ -90.00% YoY EPS Growth is 46.88% as of Mar. 2021.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Predictive Technology Group's YoY EPS Growth for the quarter that ended in Mar. 2021 was 46.88%.

Predictive Technology Group's Earnings per Share (Diluted) for the three months ended in Mar. 2021 was $-0.02.

Predictive Technology Group YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Predictive Technology Group's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Predictive Technology Group YoY EPS Growth Chart

Predictive Technology Group Annual Data
Trend Jun18 Jun19 Jun20
YoY EPS Growth
- -128.57 -413.02

Predictive Technology Group Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -241.91 -381.13 -84.29 74.18 46.88

Predictive Technology Group YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Predictive Technology Group's YoY EPS Growth for the fiscal year that ended in Jun. 2020 is calculated as:

YoY EPS Growth (A: Jun. 2020 )
=(Earnings per Share (Diluted) (A: Jun. 2020 )-Earnings per Share (Diluted) (A: Jun. 2019 ))/ | Earnings per Share (Diluted) (A: Jun. 2019 ) |
=(-0.2955--0.0576)/ | -0.0576 |
=-413.02 %

Predictive Technology Group's YoY EPS Growth for the quarter that ended in Mar. 2021 is calculated as:

YoY EPS Growth (Q: Mar. 2021 )
=(Earnings per Share (Diluted) (Q: Mar. 2021 )-Earnings per Share (Diluted) (Q: Mar. 2020 )) / | Earnings per Share (Diluted) (Q: Mar. 2020 )) |
=(-0.0247--0.0465)/ | -0.0465 |
=46.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 46.88% mean?
Predictive Technology Group (PREDQ) has a YoY EPS Growth of 46.88% as of Mar. 2021. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Predictive Technology Group and its competitors.
Is Predictive Technology Group's YoY EPS Growth too high?
Predictive Technology Group's current YoY EPS Growth is 46.88%.
How does Predictive Technology Group's YoY EPS Growth compare to GLMD and RCAR?
Predictive Technology Group's YoY EPS Growth of 46.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Biotechnology company?
A good YoY EPS Growth depends on the Biotechnology industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Predictive Technology Group and its competitors. Predictive Technology Group's current YoY EPS Growth is 46.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predictive Technology Group stock overvalued right now?
Predictive Technology Group (PREDQ) has a current YoY EPS Growth of 46.88%. The current YoY EPS Growth is 46.88%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Predictive Technology Group (PREDQ), the current YoY EPS Growth is 46.88% as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Predictive Technology Group Business Description

Address 2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.